USPTO serial 72264499
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
LENEXA, KS
KANSAS CITY, MO
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
BRISTOL, TN
Other trademarks owned by KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gianni P. Servodidio
GIANNI P SERVODIDIO JENNER & BLOCK LLP37TH FL919 3RD AVENEW YORK, NY 10022-3908| Class | Description | Status | First use |
|---|---|---|---|
| 018 | ANTIHISTAMINE | EXPIRED | Dec 16, 1966 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 4, 2009 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Nov 10, 2008 | CFIT | CASE FILE IN TICRS | — |
| Mar 27, 2006 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2006 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 10, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 2, 1988 | REN1 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) | — |
| Apr 22, 1988 | 9.AF | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 | — |